Disease awareness advertising: Women's intentions following exposure

Australian Family Physician

Volumn 40, Issue 3, 2011, Pages 143-147

  Hall, Danika ^a   Jones, Sandra ^a   Iverson, Don ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Doctor patient relations; Education, health (to lay people); Public health; Public health policy

Indexed keywords

ADVERTIZING; AGED; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; BEHAVIOR; FEMALE; FIBROMYALGIA; HEALTH EDUCATION; HUMAN; INFORMATION SEEKING; METABOLIC BONE DISEASE; MIDDLE AGED; PATIENT ATTITUDE; PERCEPTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STATISTICS; VERY ELDERLY;

ADVERTISING AS TOPIC; AGED; AGED, 80 AND OVER; AUSTRALIA; BONE DISEASES, METABOLIC; FEMALE; FIBROMYALGIA; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION SEEKING BEHAVIOR; INTENTION; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PERCEPTION; QUESTIONNAIRES;

EID: 79952670633     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Moynihan R, Cassels A. Selling sickness: how drug companies are turning us all into patients. Sydney: Allen & Unwin, 2005.
2. Angell M. The truth about the drug companies: how they deceive us and what to do about it. Melbourne: Scribe Publications, 2006.
3. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ 2002;324:886-91.
4. Mansfield PR, Lexchin J, Wen LS, et al. Educating health professionals about drug and device promotion: advocates' recommendations. PLoS Med 2006;3:1988-91.
5. Mansfield P, Mintzes B, Richards D, et al. Direct to consumer advertising. BMJ 2005;330:5-6.
6. Mintzes B. Disease mongering in drug promotion: do governments have a regulatory role? PLoS Med 2006;4:1-5.
7. Medicines Australia. Code of Conduct. 16th edn, 2009. Available at www.medicinesaustralia.com.au/pages/images/Code-of-Conduct-Edition-16-Final.pdf [Accessed 11 November 2009].
8. t'Jong GW, Stricker BHC, Sturkenboom MCJM. Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study. BMJ 2004;328:931.
9. Basara LR. The impact of a direct-to-consumer prescription medication advertising campaign on new prescription volume. Drug Inf J 1996;30:715-29.
10. East M. Pharmaceutical campaigns pull patients in. Australian Doctor 2010;14:3.
11. Hall DV, Jones SC, Iverson DC. A content analysis of disease awareness advertisements in popular Australian women's magazines. Med J Aust 2009;191:625-9.
12. Bell RA, Wilkes MS, Kravitz RL. The educational value of consumer-targeted prescription drug print advertising. J Fam Pract 2000;49:1092-8.
13. Auton F. The advertising of pharmaceuticals direct to consumers: a critical review of the literature and debate. International Journal of Advertising 2004;23:5-52.
14. Auton F. The patient as consumer: the advertising of pharmaceuticals to consumers should be allowed and encouraged. Economic Affairs, June 2007:64-72.
15. Wielondek M. Can direct-to-consumer advertising help in re-inventing the image of the pharmaceutical industry instead of eroding its credibility? Journal of Medical Marketing 2005;5:264-73.
16. Osteoporosis Australia. Frequently asked questions. Available at www.osteoporosis.org.au/osteo_faq.php [Accessed 27 July 2010].
17. Arthritis Australia. Fibromyalgia. Available at www.arthritisvic.org.au/downloads/Fibromyalgia.pdf [Accessed 27 July 2010].
18. Berenson A. Drug approved. Is disease real? The New York Times, 14 January 2008.
19. Alonso-Coello P, Garcia-Franco AL, Guyatt G. Drugs for pre-osteoporosis: prevention or disease mongering? BMJ 2008;336:126-9.
20. The Royal Australian College of General Practitioners. Recommendations for the prevention and treatment of osteoporosis in postmenopausal women and older men. South Melbourne: RACGP, 2010. Available at www.racgp.org.au/guidelines/musculoskeletaldiseases/osteoporosis [Accessed 9 August 2010].
21. Kelleher S. Disease expands through marriage of marketing and machines. The Seattle Times, 28 June 2005.
22. Ee C. I just don't feel right. Aust Fam Physician 2008;37:904-7.
23. McCrum-Gardner E. Which is the correct statistical test to use? Br J Oral Maxillofac Surg 2008;46:38-41.
24. Murray E, Lo B, Pollack L, et al. Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship. J Am Board Fam Pract 2003;16:513-24.
25. MHRA. The Blue Guide: advertising and promotion of medicines in the UK, Annex 3: Disease Awareness Campaign Guidelines. Medicines and Healthcare Products Regulatory Agency, 2005. Available at www.mhra.gov.uk/Howweregulate/Medicines/Advertisingofmedicines/index.htm [Accessed 7 July 2007].
26. Wolfe F, Aarflot T, Bruusgaard D, et al. Fibromyalgia and disability: report of the Moss International Working Group on medico-legal aspects of chronic widespread musculoskeletal pain complaints and fibromyalgia. Scand J Rheumatol 1995;24:112-8.
27. University of South Australia, The University of Adelaide, South Australian Department of Health. Musculoskeletal conditions: osteoporosis. Adelaide: South Australian Department of Health, 2007.